Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

ID DOID:4305
Name bone giant cell tumor
Definition A benign giant cell tumor that results_in the presence of multinucleated giant cells.
Source DiseaseOntology.org
Alt Ids
Path disease disease of cellular proliferation benign neoplasm organ system benign neoplasm musculoskeletal system benign neoplasm connective tissue benign neoplasm bone benign neoplasm benign giant cell tumor bone giant cell tumor

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT00680992 Phase II Denosumab Study of Denosumab in Subjects With Giant Cell Tumor of Bone Completed USA | SWE | POL | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUT | AUS 0
NCT03301857 Phase III Denosumab Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 Completed USA | SWE | POL | ITA | GBR | FRA | ESP | AUS 0
NCT03605199 Phase II Denosumab Denosumab in Subjects With Giant Cell Rich Tumors of Bone Unknown status NLD | ITA | FRA 0